GRANDPHARMA

00512

5.1601.34% ( -0.070 )

Delay Closed: Jul 31, 16:08:00

FY2025 Earnings

Financial report interval: 2024.12.31 - 2025.12.31

Preview: GRANDPHARMA(00512) predict that the Revenue is 12.28 B (+5.48%), Beat estimate;the EBIT is 1.656 B (-45.38%), Miss estimate;the EPS is 0.354 (-49.72%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

12.28B5.48%

12.18B4.58%

+0.10B0.90%

EBITMiss expectations

1.66B45.38%

2.69B11.25%

-1.03B34.13%

EPSMiss expectations

0.354449.72%

0.6113.46%

-0.255636.26%

Revenue

ActualEstimateUnit: HKD

EBIT

ActualEstimateUnit: HKD

Net income

ActualEstimateUnit: HKD

EPS

ActualEstimateUnit: HKD